Impact of Vehicle Physicochemical Properties on Modeling-Based Predictions of Cyclosporine Ophthalmic Emulsion Bioavailability and Tear Film Breakup Time

Abstract

Several physicochemical parameters are thought to affect in vivo performance of cyclosporine ophthalmic emulsion, including globule size distribution, viscosity profile as a function of applied shear, pH, zeta potential, osmolality, and surface tension. Using a modeling approach, this study predicts cyclosporine ophthalmic emulsion drug bioavailability to the cornea and conjunctiva and tear film breakup time for human subjects as a function of the vehicle physicochemical properties viscosity, surface tension, and osmolality for products that are qualitatively (Q1) and quantitatively (Q2) the same. The change in tear film breakup time from baseline, a potential indirect measure of therapeutic benefit, was predicted to characterize the direct effect of the vehicle on efficacy. Bioavailability predictions showed that while individual predictions were sensitive to variations in corneal and conjunctival permeabilities, geometric mean ratios of the test-to-reference comparisons for formulations that are Q1 and Q2 the same showed little sensitivity. Parameter sensitivity analysis showed that bioavailability and change in tear film breakup time from baseline values were both very sensitive to viscosity, slightly sensitive to surface tension, and insensitive to osmolality. With further improvements, the modeling framework developed for this study may be useful for informing future recommendations of cyclosporine ophthalmic emulsion bioequivalence for potential generic drug products.

In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery

“…Low formulation viscosity enables dosing accuracy and ease of eye-drop administration. Surface tension is an important physicochemical formulation parameter that determines spreading of a formulation across the ocular surface and also influences capillary drainage through the nasolacrimal ducts, affecting precorneal residence time of the instilled formulation (20). As expected, with the increase in cationic surfactant concentration, the surface tension of SANE formulation decreased.…”

“…NE technology has an increasing influence in every aspect of drug delivery (16)(17)(18), particularly in ophthalmic drug delivery (2,19). Physicochemical properties affecting in vivo performance of an ophthalmic NE include droplet size, size distribution and zeta-potential, formulation viscosity profile as a function of applied shear, pH, osmolarity, and surface tension (20,21). In order to develop a stable cationic NE with SA as a carrier of positive charge, we first performed screening of ophthalmically acceptable oils and nonionic surfactants in search for primary formulation with small droplet size and low PDI value.…”

Innovation for Generic Drugs: Science and Research Under the Generic Drug User Fee Amendments of 2012

“…For ophthalmic products, the FDA's ophthalmic research program integrates different aspects of Q3 evaluation on new methodologies for characterization of physicochemical properties of ophthalmic drug products, development, and evaluation of in vitro release testing methods and their capacity to predict in vivo performance and development of predictive modeling of ocular drug absorption …”

Kalium Permanganat: Termodinamika Mengenai Transport Ionik dalam Air

“…Viskositas (154)(155)(156)(157)(158)(159)(160)(161) adalah suatu cara untuk menyatakan berapa daya tahan dari aliran yang diberikan oleh suatu cairan.Viskositas adalah ukuran yang menyatakan kekentalan suatu cairan atau fluida.Kekentalan merupakan sifat cairan yang berhubungan erat dengan hambatan untuk mengalir.Viskositas cairan akan menimbulkan gesekan antar bagian atau lapisan cairan yang bergerak satu terhadap yang lain.Hambatan atau gesekan yang terjadi ditimbulkan oleh gaya kohesi didalam zat cair.…”